Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CULLMAN PRIMARY CARE, PC

NPI: 1851602981 · CULLMAN, AL 35055 · Family Medicine Physician · NPI assigned 06/23/2010

$797K
Total Medicaid Paid
53,349
Total Claims
34,823
Beneficiaries
26
Codes Billed
2018-01
First Month
2023-12
Last Month

Provider Details

Authorized OfficialBLANKENSHIP, CONNIE (CREDENTIALING COORDINATOR)
Parent OrganizationCULLMAN PRIMARY CARE, PC
NPI Enumeration Date06/23/2010

Related Entities

Other providers sharing the same authorized official: BLANKENSHIP, CONNIE

ProviderCityStateTotal Paid
CULLMAN PRIMARY CARE, PC CULLMAN AL $1.67M
CULLMAN PRIMARY CARE, PC CULLMAN AL $1.13M
CULLMAN PRIMARY CARE, PC CULLMAN AL $280K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 7,375 $74K
2019 7,724 $91K
2020 5,558 $84K
2021 13,359 $168K
2022 13,058 $220K
2023 6,275 $161K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 18,946 13,418 $485K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 11,347 8,228 $103K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 5,530 3,854 $91K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 6,993 2,951 $59K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 575 464 $23K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,846 1,840 $16K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 837 529 $8K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 280 180 $4K
87807 364 282 $3K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 68 50 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,265 776 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 73 43 $576.00
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 14 12 $429.40
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 132 112 $279.14
J1100 Injection, dexamethasone sodium phosphate, 1 mg 530 316 $142.18
81003 17 13 $32.64
3074F 1,249 880 $0.00
3008F 86 56 $0.00
3079F 155 119 $0.00
2010F 32 15 $0.00
2000F 13 12 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 35 26 $0.00
2001F 30 14 $0.00
3078F 871 604 $0.00
1160F 29 14 $0.00
1159F 32 15 $0.00